V114-022/PNEU-STEM

V114-022/PNEU-STEM

A Phase 3, Randomized, Double-blind, Active Comparator-controlled, Multicenter Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Recipients of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) (PNEU-STEM)


Treatment


Inclusion criteria


Exclusion criteria


Participating sites

Link